Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients

被引:50
|
作者
Huang, Chien-Fang
Li, Tsai-Chung
Lin, Cheng-Chieh
Liu, Chlu-Shong
Shih, Hung-Chang
Lai, Ming-May
机构
[1] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[2] China Med Univ Hosp, Clin Lab, Taichung, Taiwan
[3] China Med Univ, Dept Inst Chinese Med & Publ Hlth, Taichung, Taiwan
关键词
hyperlipidemia; lipid ratio; red yeast rice;
D O I
10.1097/HJR.0b013e32801da137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several lipid ratios may be predictors of coronary artery disease risk. We assessed the efficacy of Monascus purpureus Went rice (red yeast rice) on lowering lipid ratios. Method and results We evaluated 79 hypercholesterolemic patients (aged 23-65 years) who received a twice-daily dose of either red yeast rice or a placebo at 600 mg for 8 weeks. The 8-week treatment with red yeast rice showed significantly greater reduction than the placebo treatment in low-density lipoprotein cholesterol levels, total cholesterol/high-clensity lipoprotein cholesterol, low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and apolipoprotein 13/apolipoprotein A-1 ratios. Conclusions Red yeast rice can reduce lipid ratios in hypercholesterolemic patients.
引用
收藏
页码:438 / 440
页数:3
相关论文
共 50 条
  • [41] Lipid-lowering effect of HMG co-A reductase inhibitors compared with cholestyramines on vascular enclothelium in hypercholesterolemic and hypertensive patients
    Park, SJ
    Choi, DJ
    Hwang, JY
    CIRCULATION, 2004, 110 (17) : 119 - 119
  • [42] Efficacy and safety of alirocumab 150 mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON
    Teramoto, Tamio
    Kiyosue, Arihiro
    Ishigaki, Yasushi
    Harada-Shiba, Mariko
    Kawabata, Yumiko
    Ozaki, Asuka
    Baccara-Dinet, Marie T.
    Sata, Masataka
    JOURNAL OF CARDIOLOGY, 2019, 73 (3-4) : 218 - 227
  • [43] Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes - Lipid-Lowering With Highly Potent Statins in Hyperlipidemia With Type 2 Diabetes Patients (LISTEN) Study
    Ogawa, Hisao
    Matsui, Kunihiko
    Saito, Yoshihiko
    Sugiyama, Seigo
    Jinnouchi, Hideaki
    Sugawara, Masahiro
    Masuda, Izuru
    Mori, Hisao
    Waki, Masako
    Yoshiyama, Minoru
    Watada, Hirotaka
    CIRCULATION JOURNAL, 2014, 78 (10) : 2512 - 2515
  • [44] Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease
    Abe, Masanori
    Maruyama, Noriaki
    Yoshida, Yoshinori
    Ito, Midori
    Okada, Kazuyoshi
    Soma, Masayoshi
    ENDOCRINE JOURNAL, 2011, 58 (08) : 663 - 674
  • [45] Lipid-lowering and antiaggregatory efficacy of atorvastatin in coronary heart disease patients with combined hyperlipidemia
    Viigimaa, M
    Välkman, R
    ATHEROSCLEROSIS, 1999, 144 : 24 - 24
  • [46] Lack of Association of the P450 Oxidoreductase*28 Single Nucleotide Polymorphism with the Lipid-Lowering Effect of Statins in Hypercholesterolemic Patients
    Ragia, Georgia
    Kolovou, Vana
    Tavridou, Anna
    Elens, Laure
    Tselepis, Alexandros D.
    Elisaf, Moses
    Van Schaik, Ron H. N.
    Kolovou, Genovefa
    Manolopoulos, Vangelis G.
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (03) : 323 - 331
  • [47] ROSUVASTATIN CAN REDUCE AORTIC STIFFNESS IN HYPERCHOLESTEROLEMIC PATIENTS BY FAVORABLE HEMODYNAMIC CHANGES, INDEPENDENT OF LIPID LOWERING AND ANTI-INFLAMMATORY EFFECTS
    Oh, Pyung Chun
    Han, Seung Hwan
    Seo, Jong Goo
    Suh, Soon Yong
    Lee, Kyounghoon
    Kang, Woong Chul
    Koh, Kwang Kon
    Ahn, Taehoon
    Choi, In Suck
    Shin, Eak Kyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1447 - E1447
  • [48] Lack of Association of the P450 Oxidoreductase *28 Single Nucleotide Polymorphism with the Lipid-Lowering Effect of Statins in Hypercholesterolemic Patients
    Georgia Ragia
    Vana Kolovou
    Anna Tavridou
    Laure Elens
    Alexandros D. Tselepis
    Moses Elisaf
    Ron H. N. Van Schaik
    Genovefa Kolovou
    Vangelis G. Manolopoulos
    Molecular Diagnosis & Therapy, 2014, 18 : 323 - 331
  • [49] Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients
    Inoue, T
    Hayashi, M
    Takayanagi, K
    Morooka, S
    ATHEROSCLEROSIS, 2002, 160 (02) : 369 - 376
  • [50] Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression
    Martínez-Castelao, A
    Grinyó, JM
    Gil-Vernet, S
    Serón, D
    Castiñeiras, MJ
    Ramos, R
    Alsina, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 398 - +